Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
BMC Cancer. 2010 Aug 23;10:451. doi: 10.1186/1471-2407-10-451.
BMC Cancer. 2010.
PMID: 20731872
Free PMC article.
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer.
Lawrence B, Blenkiron C, Parker K, Tsai P, Fitzgerald S, Shields P, Robb T, Yeong ML, Kramer N, James S, Black M, Fan V, Poonawala N, Yap P, Coats E, Woodhouse B, Ramsaroop R, Yozu M, Robinson B, Henare K, Koea J, Johnston P, Carroll R, Connor S, Morrin H, Elston M, Jackson C, Reid P, Windsor J, MacCormick A, Babor R, Bartlett A, Damianovich D, Knowlton N, Grimmond S, Findlay M, Print C.
Lawrence B, et al. Among authors: damianovich d.
NPJ Genom Med. 2018 Jul 20;3:18. doi: 10.1038/s41525-018-0058-3. eCollection 2018.
NPJ Genom Med. 2018.
PMID: 30062048
Free PMC article.
Item in Clipboard
Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis.
Damianovich D, Adena M, Tebbutt NC.
Damianovich D, et al.
Br J Cancer. 2007 Feb 26;96(4):546-50. doi: 10.1038/sj.bjc.6603590. Epub 2007 Feb 6.
Br J Cancer. 2007.
PMID: 17285136
Free PMC article.
Item in Clipboard
A case of cardiogenic shock caused by capecitabine treatment.
To AC, Looi KL, Damianovich D, Taylor GB, Sidebotham D, White HD.
To AC, et al. Among authors: damianovich d.
Nat Clin Pract Cardiovasc Med. 2008 Nov;5(11):725-9. doi: 10.1038/ncpcardio1352. Epub 2008 Sep 23.
Nat Clin Pract Cardiovasc Med. 2008.
PMID: 18813211
Item in Clipboard
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators.
Rha SY, et al.
Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21.
Lancet Oncol. 2023.
PMID: 37875143
Clinical Trial.
Item in Clipboard
Cite
Cite